January 29, 2021
Life Science Institute, a Mitsubishi Chemical group company, said on January 28 that it will start an exploratory clinical trial in Japan for its multi-lineage differentiating stress enduring (Muse) cell therapy CL2020 for the treatment of amyotrophic lateral sclerosis (ALS)...read more